Switch to:
More From Other Websites
Another Endorsement for Biotech ETFs Aug 16 2016
Biotech Breakout: Take 3 Aug 04 2016
Big Biotech Buyout Banter Buoys IBB Aug 02 2016
How Much Will BioMarin’s Kuvan Fetch in 2Q16? Aug 02 2016
What’s behind the Recent Fall in Alexion’s Valuation Multiple? Jul 25 2016
How Much Will Orkambi Fetch for Vertex Pharmaceuticals in 2Q16? Jul 22 2016
How Can Alexion Stay ahead of the Competition with Soliris? Jul 22 2016
ALNY Should Complete Revusiran’s Endeavour Trial Enrollment in Late 2016 Jul 14 2016
Biotech ETFs: Will the Once Hot Group Rebound? Jul 13 2016
Inside Alnylam Pharmaceuticals’s Analyst Recommendations in 2016 Jul 08 2016
Regeneron in 2Q16: How Much Revenue Growth Could It Have? Jul 08 2016
Inside BioMarin’s Big Plans for 3Q16 Jul 06 2016
Biotechs Building Base?...Or Bursting Bubble? Jun 30 2016
BioMarin’s Guidance for 2016: The Inside Story Jun 29 2016
As Cost Panel Gets Delayed, Buy These 3 Biotech ETFs Jun 23 2016
Expect More Election Year Volatility For Biotech ETFs Jun 21 2016
Biotech Bounce: Sizzle Or Fizzle? Jun 06 2016
A Catalyst for Biotech ETFs Jun 06 2016
Trying to Believe in Biotech ETFs Jun 03 2016
Finally A Biotech ETF Bounce? Jun 01 2016


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK